|
Checkpoint Therapeutics, Inc. (CKPT) Évaluation DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Checkpoint Therapeutics, Inc. (CKPT) Bundle
Vous cherchez à calculer la valeur intrinsèque de Checkpoint Therapeutics, Inc.? Notre calculatrice DCF (CKPT) intègre des données réelles avec des fonctionnalités de personnalisation complètes, vous permettant d'ajuster les prévisions et d'améliorer vos stratégies d'investissement.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.7 | 1.1 | .3 | .2 | .1 | .1 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | -37.41 | -74.93 | -28.36 | -46.35 | -46.76 | -46.76 | -46.76 | -46.76 | -46.76 |
| EBITDA | -24.9 | -23.2 | -56.7 | -58.3 | -52.1 | -.1 | .0 | .0 | .0 | .0 |
| EBITDA, % | -1454.92 | -2170.35 | -21165.3 | -30381.77 | -50629.13 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .2 | .2 | .2 | 4.5 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 10.06 | 19.3 | 88.27 | 2318.23 | 0 | 43.53 | 43.53 | 43.53 | 43.53 | 43.53 |
| EBIT | -25.0 | -23.4 | -57.0 | -62.8 | -52.1 | -.1 | .0 | .0 | .0 | .0 |
| EBIT, % | -1464.98 | -2189.64 | -21253.57 | -32700 | -50629.13 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 26.1 | 40.8 | 54.7 | 12.1 | 4.9 | .1 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 1.52 | 1.87 | 6.34 | 38.02 | 0 | 9.55 | 9.55 | 9.55 | 9.55 | 9.55 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0.000058548009 | 0.00009354537 | 0 | 0.000520833333 | 0 | 0.000134585342 | 0.000134585342 | 0.000134585342 | 0.000134585342 | 0.000134585342 |
| Accounts Payable | 3.1 | 3.4 | 16.1 | 11.5 | 6.6 | .1 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 180.27 | 321.61 | 6022.01 | 6007.81 | 6378.64 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -24.9 | -23.3 | -56.9 | -67.1 | -52.1 | -.1 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -21.7 | -22.7 | -44.0 | -67.3 | -57.0 | -6.6 | .0 | .0 | .0 | .0 |
| WACC, % | 10.44 | 10.44 | 10.44 | 10.44 | 10.44 | 10.44 | 10.44 | 10.44 | 10.44 | 10.44 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -6.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -6 | |||||||||
| Net Debt | -5 | |||||||||
| Equity Value | -1 | |||||||||
| Diluted Shares Outstanding, MM | 19 | |||||||||
| Equity Value Per Share | -0.06 |
What You Will Get
- Comprehensive CKPT Financials: Access historical and projected data for precise valuation.
- Customizable Parameters: Adjust discount rates, tax implications, revenue forecasts, and investment levels.
- Real-Time Calculations: Intrinsic value and NPV are computed automatically.
- Scenario Modeling: Explore various scenarios to assess Checkpoint Therapeutics' future potential.
- User-Friendly Interface: Designed for industry experts while remaining approachable for newcomers.
Key Features
- Comprehensive CKPT Financial Data: Gain access to precise pre-loaded historical financials and future forecasts.
- Adjustable Forecast Parameters: Modify highlighted cells for key metrics such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic adjustments for DCF, Net Present Value (NPV), and cash flow assessments.
- User-Friendly Dashboard: Intuitive charts and summaries to help visualize your valuation outcomes.
- Suitable for All Levels: A straightforward, easy-to-navigate layout designed for investors, CFOs, and consultants alike.
How It Works
- Step 1: Download the prebuilt Excel template featuring Checkpoint Therapeutics, Inc. (CKPT) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the recalculated results, including Checkpoint Therapeutics, Inc.'s (CKPT) intrinsic value.
- Step 5: Make well-informed investment choices or create reports based on the outputs.
Why Choose This Calculator for Checkpoint Therapeutics, Inc. (CKPT)?
- Designed for Experts: A sophisticated tool utilized by biotech analysts, CFOs, and investment consultants.
- Accurate Data: Checkpoint Therapeutics’ historical and projected financials are preloaded for precision.
- Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance makes the process straightforward.
Who Should Use Checkpoint Therapeutics, Inc. (CKPT)?
- Investors: Gain insights into innovative oncology solutions to inform your investment choices.
- Healthcare Analysts: Streamline your research with comprehensive data on drug development and market potential.
- Consultants: Effortlessly modify reports and presentations tailored to client needs in the biopharmaceutical sector.
- Biotech Enthusiasts: Enhance your knowledge of cutting-edge cancer therapies through real-world case studies.
- Educators and Students: Utilize as a valuable resource for learning about the biotechnology industry and drug commercialization.
What the Template Contains
- Pre-Filled DCF Model: Checkpoint Therapeutics, Inc.'s (CKPT) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital specific to (CKPT).
- Financial Ratios: Evaluate Checkpoint Therapeutics, Inc.'s (CKPT) profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios for (CKPT).
- Financial Statements: Annual and quarterly reports to support detailed analysis of Checkpoint Therapeutics, Inc. (CKPT).
- Interactive Dashboard: Easily visualize key valuation metrics and results for (CKPT).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.